Amazon founder Jeff Bezos has invested $3 billion in startup Altos Labs, which will develop a cellular rejuvenation program. writes The Sunday Times.
The startup will develop biological technology to restore the health of cells, their resistance to disease, injury, and even disability.
The Institutes of Science will be involved in research, and the Institute of Medicine will be in the development of a drug. They will be located in San Francisco and San Diego, as well as in British Cambridge. The company also plans to cooperate with Japan.
Altos Labs’ board of directors includes Nobel Prize winners in chemistry Jennifer Doudna (2020, genetic engineering) and Frances Arnold (2018, enzyme applications). Rick Klausner and Hans Bishop became co-chairs of the council. Hal Barron, chief scientific officer and president of research and development at the British pharmaceutical company GSK, is also among them. He will move to a startup from August 1.
Jeff Bezos Makes Biggest Donation to the Obama Foundation